Skip to main content

Dave Muoio

By Dave Muoio | 02:56 pm | February 16, 2021
SNP chip data often reported by consumer genomics companies should not be considered for clinical decisions without additional validation, warn researchers.
By Dave Muoio | 02:05 pm | February 15, 2021
The device reportedly will include a cellular connection and could tie in with third-party health and wellness services, such as those offered by Peloton.
By Dave Muoio | 04:50 pm | February 12, 2021
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.
By Dave Muoio | 03:33 pm | February 11, 2021
The company said that its platform is currently in use among more than 4,800 emergency communications centers across the U.S.
By Dave Muoio | 01:29 pm | February 11, 2021
This is the third funding round for Modern in about 13 months, and propels the San Francisco company to unicorn status.
By Dave Muoio | 03:03 pm | February 10, 2021
New research suggests that the wearable could help identify COVID-19 cases up to seven days before a positive diagnostic test.
By Dave Muoio | 04:22 pm | February 09, 2021
Also: Base launches home wellness testing subscription with $3.4 million raise; Daybreak Health delivers online counseling to teens with $1.8 million seed round.
By Dave Muoio | 03:39 pm | February 09, 2021
Thirty mobile health apps from larger healthcare information technology companies were susceptible to a broken object level authorization (BOLA) attack.
By Dave Muoio | 12:59 pm | February 09, 2021
Saykara's founder and team will be augmenting Nuance's R&D division.
By Dave Muoio | 03:47 pm | February 08, 2021
Founded in 2012, Oscar has grown to an approximate membership of 529,000, an annual revenue of $1.67 billion and a lifetime accumulated deficit of $1.43 billion.